News About: Pharm. Industry
Dent on drug maker's image
Market watchers predict the impact of the data fabrication on domestic pharmaceutical industry is more serious than financial loss, as the Korea Food and Administration unveiled the second results of forged bioequival...
New recombinant FSH agent to make debut soon
The Korea Food and Drug Administration (KFDA) approved LG Life Sciences' Follitrope, a recombinant follicle stimulating hormone (FSH).
This hormone is identical to the follicle-stimulating hormone (FSH) produced by...
Local drug makers win patent nullification trial over Plavix
On June 28, a patent trial board ruled against Plavix (clopidogrel) patent in its nullification trial which had been sought by some local pharmaceutical firms.
Plavix is an anti-clotting agent that is the world's ...
Pharmaceutical firms vying for anti-osteoporosis market
Pharmaceutical companies are vying for a bigger share of the domestic anti-osteoporosis market as a growing number of Korean women are suffering from osteoporosis.
Osteoporosis is a global problem, affecting more t...
KRPIA members to obey revised ethical code from Oct.
26 member companies of the KRPIA, a foreign multinational drug corporation group in Korea, kept promise to comply to the newly revised code of ethics from coming Oct.
The member group took a meeting called "A works...
Positive list system may not save NHI finance.
The pharmaceutical industry suggested a way of better NHI financial saving than the positive list system, which included more patient's own payment for minor disease treatments, reclassification of the prescription an...
Chronic disease-related drugs output grows in 2005
Korea saw the production increase of 'drugs acting on circulatory system', 'drugs on peptic ulcers' and 'other metabolic agents' associated with chronic diseases in 2005, while the output of tonics fell due to a slugg...
General hospitals to get freedom of direct transaction
General hospitals will now be able to enjoy more freedom in the direct transaction of drugs, as the government plans to gradually ease regulations on the unified distribution by drug wholesalers.
The Ministry of He...
Lee Jin named as Pfizer Korea's new press chiefOn July 3, Pfizer Korea appointed Lee Jin, senior presidential secretary for public information, as new press chief for public cooperation.
Lee, 40, replaces Pfizer Korea's d...
|
Pacific Pharm's Meditoxin eyes bigger market sharePacific Pharm plans to expand its share of the domestic botulinum toxin market dominated by foreign brands Allergan's Botox, Ipsen's Dysport, Chinese labs' BTX-A - and the mark...
|
